Lot Release Certificate View

Lot Release Number 2019-10-08-0259
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
Brand Name Hexaxim
Dosage Strength 0.5 mL
Dosage Form Suspension for Injection (I.M.)
Registration Number BR-919
Batch/Lot Number R3F98
Packaging Lot Packaging lot: R3F981V Pre-filled syringe: R3F98 Needle 25G x 5/8": 1905025 Needle 23G x 1": 1905001
Product Expiration Date 31 March 2021
Issuance Date 11 October 2019